PLGF anticorps

N° du produit ABIN6252802

Détail du produit anti-PLGF anticorps

Antigène: PLGF (PGF) (Placenta Growth Factor (PGF))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp PLGF est non-conjugé

Application: Western Blotting (WB), ELISA, Functional Studies (Func)

Purification: Protein G affinity chromatography

Immunogène: Recombinant human protein was used as the immunogen for this PLGF antibody.

Clone: PLGF-93

Isotype: IgG1 kappa

Information d'application

Indications d'application: ELISA: order the BSA/azide free format

Functional Studies: order the BSA/azide free PLGF antibody format

The optimal dilution of the PLGF antibody for each application should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: PBS with 0.1 mg/mL BSA and 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot and Store at -20C. Avoid freez-thaw cycles.

Détails sur PLGF

Antigène: PLGF (PGF) (Placenta Growth Factor (PGF))

Autre désignation: PLGF (PGF Produits)

Synonymes: anticorps D12S1900, anticorps PGFL, anticorps PLGF, anticorps PlGF-2, anticorps SHGC-10760, anticorps AI854365, anticorps PIGF, anticorps Plgf, anticorps PlGF, anticorps placental growth factor, anticorps placenta growth factor, anticorps PGF, anticorps Pgf, anticorps PLGF

Sujet: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta, the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

ID gène: 5228

UniProt: P49763

Pathways: VEGFR1 Specific Signals